NeoImmuneTech Welcomes a New President for its Development and Business

ROCKVILLE, Md., Jan. 15, 2024 -- (Healthcare Sales & Marketing Network) -- NeoImmuneTech, Inc. (NIT or "NeoImmuneTech"), a clinical-stage T cell-focused biopharmaceutical company, today announces the appointment of Luke Oh, Ph.D., as President, ... Biopharmaceuticals, Oncology, Personnel NeoImmuneTech, efineptakin alfa, Acute Radiation Syndrome
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news